Search for the latest updates on diabetes
News
FDA warns that SGLT2 inhibitors for diabetes may result in too much acid in the blood The Atascocita Observer - 36 minutes
The U.S. Food and Drug Administration (FDA) is warning that the type 2 diabetes medicines canagliflozin, dapagliflozin, and empagliflozin may ...
Manage alerts · Privacy Policy
Tip: To search for an exact phrase, put quotation marks around two or more words.
| You received this email because you subscribed to Yahoo! Search. |
No comments:
Post a Comment